Roche Diagnostics at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Roche Diagnostics brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on measuring what gene therapy tools do in tissue. Topics include quantifying the biologically active fraction of rAAV in living animals and optical pooled screening to find gene regulatory elements specific to a cell type.

OrganizationESGCT 2026 Attendance
diagnostics.roche.com
Tools & reagents
Roche's diagnostics division, making instruments, tests and reagents; its German company also hosts Roche biologics research at Penzberg.
Poster
Thu Oct 29
2:00pm–4:00pm
AAVengers: Measuring the Biologically Active Fraction of rAAV In Vivo
AAVs / non integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
OpticalMPRA: An optical pooled screening approach to identify cell type specific gene regulatory elements in complex tissue.
Other
Vectors and delivery (AAV, lentiviral, LNP)

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Roche Diagnostics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction